Finding the cause of pain or health issue, then getting the required treatment, shouldn't require patients to visit several different practices. For men and women in the Baltimore area, becoming a patient of Advanced Medical Center is highly convenient. The office's integrated medical clinic allows families near Rosedale, Roland Park, Towson, and Pikesville, Maryland, to get all of their medical needs met under one roof. What makes Advanced Medical Center different is from other clinics is that the doctors and medical team believe that symptoms are the body's way of telling a patient something is off, even if it's a minor health issue. The clinic's medical professionals have extensive training and experience in reading symptoms and signals, then putting together a diagnosis and treatment plan. The practitioners at Advanced Medical Center work to treat any underlying medical problems men and women may have, rather than masking the issue with medications or temporary relief options. They work to get patients back to optimal overall health. Advanced Medical Center is truly a one-stop-shop for improved health. Patients of the practice get help with physical therapy, joint injections, spinal screenings, cardiovascular health, and headache management. The practice is accepting new patients and offers flexible appointments that fit around a busy schedule.
Dr. Harry A. Silber is an associate professor of medicine at the Johns Hopkins University School of Medicine. His clinical work specializes in cardiac disease and his research focuses on vascular function by MRI and non-invasive assessment of cardiac filling pressure.Dr. Silber received a doctorate in biomedical engineering as well as a medical degree from Tulane University. He completed a residency at the Hospital of the University of Pennsylvania before being selected for a fellowship in cardiology at Johns Hopkins Hospital. He joined the Johns Hopkins faculty in 2000.Dr. Silber has published extensively and holds several patents for his research for cardiovascular disease.
Closed now
MedStar Good Samaritan Hospital is an adult care community teaching hospital that provides comprehensive health care ranging from geriatrics and renal care to diabetes and rehabilitation services.
Dr. Bhargava developed an interest in immunology early in medical school at the Christian Medical College in Vellore, India. He then completed his neurology training at the Southern Illinois University School of Medicine and while there began research in the field of multiple sclerosis (MS). Following his neurology training he completed a 3-year fellowship at the Johns Hopkins University in neuroimmunology and neurological infections focusing on MS clinical care and research. His fellowship training was supported by a Sylvia Lawry physician fellowship award from the National MS Society.His main research interests include studying the role of inflammation in the meninges in progression of MS disease. He is currently involved in a trial testing the utility of injecting a drug called rituximab into the spinal fluid in patients with progressive MS. He is also developing an animal model of the process of meningeal inflammation to test other potential treatments. This work is supported by awards from the National MS Society, Race to Erase MS and the American Academy of Neurology.He is also actively involved in studying the role of measuring lipids and small molecule metabolites in serum and plasma to help identify new biomarkers for improved diagnosis and prognosis of the disease. These methods could also help in better tracking the effects of various interventions and in personalizing the treatment of patients with MS.
Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the JohnsHopkins Comprehensive Neurofibromatosis Center anddirector of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care.
